{"id":"chromocarb","rwe":[{"pmid":"40525420","year":"2025","title":"Identification of Potential FDA-Approved Inhibitors of SARS-CoV-2 Helicase Through a Multistep In silico Approach: A Promising Prospect for COVID-19 Treatment.","finding":"","journal":"Medicinal chemistry (Shariqah (United Arab Emirates))","studyType":"Clinical Study"},{"pmid":"11878815","year":"2002","title":"Oral flavonoids, chromocarb diethylamine salt and cyaninosides chloride, to eliminate lipoperoxidation postvitrectomy.","finding":"","journal":"Experimental eye research","studyType":"Clinical Study"},{"pmid":"3247183","year":"1988","title":"[Kinetic study of 14C chromocarb in the pigmented rabbit after a single instillation].","finding":"","journal":"Ophtalmologie : organe de la Societe francaise d'ophtalmologie","studyType":"Clinical Study"},{"pmid":"3358250","year":"1988","title":"[Double-blind controlled study of the effects of diethylamine chromocarb on venous compliance and capillary resistance in man. Pharmacological effect/plasma concentrations ratio].","finding":"","journal":"Therapie","studyType":"Clinical Study"},{"pmid":"3034470","year":"1987","title":"Effect of chromocarb diethylamine on the permeability of the blood-brain barrier.","finding":"","journal":"Clinical physiology and biochemistry","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"campel","offLabel":[],"synonyms":["chromocarb","2-Chromonecarboxylic acid","campel","atremon","4-Oxochromene-2-carboxylic acid"],"timeline":[],"approvals":[],"brandName":"Campel","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"In plain English, Campel is a small molecule that binds to a specific protein or receptor in the body, which helps to regulate various cellular processes. This binding action triggers a series of downstream effects that ultimately lead to the desired therapeutic outcome. By modulating this biological pathway, Campel aims to treat a specific disease or condition.","oneSentence":"Campel works by interacting with a specific biological target to produce a therapeutic effect.","technicalDetail":"Campel is a small molecule that acts as a ligand for a specific receptor or enzyme, triggering a conformational change that activates or inhibits downstream signaling pathways, ultimately leading to changes in gene expression or cellular function."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/628","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CHROMOCARB","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:59:29.511573","biosimilars":[],"competitors":[],"genericName":"chromocarb","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"004168","UNII":"FY38S0790W","CHEBI":"CHEBI:113552","INN_ID":"2786","UMLSCUI":"C0304535","ChEMBL_ID":"CHEMBL83628","KEGG_DRUG":"D07695","PDB_CHEM_ID":"AO7","PUBCHEM_CID":"2741","SNOMEDCT_US":"29783009","MESH_SUPPLEMENTAL_RECORD_UI":"C031334"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":8,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2025","pmid":"40525420","title":"Identification of Potential FDA-Approved Inhibitors of SARS-CoV-2 Helicase Through a Multistep In silico Approach: A Promising Prospect for COVID-19 Treatment.","journal":"Medicinal chemistry (Shariqah (United Arab Emirates))"},{"date":"2002 Jan","pmid":"11878815","title":"Oral flavonoids, chromocarb diethylamine salt and cyaninosides chloride, to eliminate lipoperoxidation postvitrectomy.","journal":"Experimental eye research"},{"date":"1988 Jul-Sep","pmid":"3247183","title":"[Kinetic study of 14C chromocarb in the pigmented rabbit after a single instillation].","journal":"Ophtalmologie : organe de la Societe francaise d'ophtalmologie"},{"date":"1988 Jan-Feb","pmid":"3358250","title":"[Double-blind controlled study of the effects of diethylamine chromocarb on venous compliance and capillary resistance in man. Pharmacological effect/plasma concentrations ratio].","journal":"Therapie"},{"date":"1987","pmid":"3034470","title":"Effect of chromocarb diethylamine on the permeability of the blood-brain barrier.","journal":"Clinical physiology and biochemistry"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Campel (CHROMOCARB) is a small molecule modality developed by an unknown entity, currently owned by an unknown entity. Its target and drug class are unknown, and it has not been approved by the FDA for any indications. The commercial status of Campel is unclear, and it is unknown whether it is patented or available as a generic. Key safety considerations for Campel are also unknown. Further research is needed to understand the pharmacology and clinical utility of this compound.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}